CNBC Halftime Report Final Trades: Amazon, KKR & Co, Natera
$AMZN
$KKR
$NTRA
Catalog/Specialty Distribution
Consumer Discretionary
Investment Managers
Finance
- CNBC
- CNBC
Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 11/14/2024 | $210.00 → $250.00 | Buy | Needham | |
| 11/1/2024 | $215.00 → $235.00 | Outperform | Telsey Advisory Group | |
| 11/1/2024 | $225.00 → $245.00 | Buy | Monness Crespi & Hardt | |
| 10/16/2024 | $750.00 → $800.00 | Buy | Loop Capital | |
| 10/11/2024 | $245.00 | Sector Outperform | Scotiabank | |
| 10/11/2024 | $260.00 | Buy | Pivotal Research Group | |
| 10/9/2024 | $230.00 → $210.00 | Overweight | Cantor Fitzgerald | |
| 10/7/2024 | $225.00 → $183.00 | Overweight → Equal Weight | Wells Fargo |
Biosynth, a global supplier of critical raw materials and services to the life sciences industry, today announced that its Board of Directors has appointed Matt Gunnison as the company's new Chief Executive Officer and a member of the Board of Directors, effective immediately. The Board has also appointed Kieran Murphy as Chairman, effective as of the same date. Matt Gunnison will succeed Urs Spitz, under whose guidance Biosynth has achieved remarkable growth and strengthened its position in the life sciences sector. Urs Spitz will remain a member of the Board of Directors. "We are grateful to Urs for his significant contributions in shaping Biosynth into the innovative and thriving compa
New leadership and reorganization will foster the next chapter of growth and enhance business operations to best support evolving client and CRO partner needs on a global scale. MALVERN, Pa., Oct. 29, 2024 /PRNewswire/ -- Resolian, a leading global bioanalytical and analytical sciences partner supporting drug development and multi-regional clinical trials, today announced several leadership changes as the company expands its global footprint and operational capabilities. Rob Stachlewitz will join Resolian as Chief Executive Officer (CEO), while current CEO Pat Bennett will transition into the newly created role of Chief Business Officer and President of Scientific Affairs. In addition, the
Amazon Ads announced several new capabilities that leverage its deep, full-funnel insights to help brands launch new products and extend its sophisticated measurement and optimization ad tech to all advertisers (NASDAQ:AMZN) — At unBoxed 2024, Amazon Ads launched a suite of new advertising capabilities that bring together insights from across the marketing funnel to help advertisers optimize their media investments. The announcements showcased how Amazon Ads is making its powerful insights easier to access and activate by every advertiser, across every ad product. "Our mission is to be the most customer-obsessed advertising service by giving all brands the measurement and data-driven, mac
10-Q - Natera, Inc. (0001604821) (Filer)
8-K - Natera, Inc. (0001604821) (Filer)
13F-HR - AMAZON COM INC (0001018724) (Filer)
4 - Natera, Inc. (0001604821) (Issuer)
4 - AMAZON COM INC (0001018724) (Issuer)
4 - AMAZON COM INC (0001018724) (Issuer)
Needham reiterated coverage of Amazon with a rating of Buy and set a new price target of $250.00 from $210.00 previously
Telsey Advisory Group reiterated coverage of Amazon with a rating of Outperform and set a new price target of $235.00 from $215.00 previously
Monness Crespi & Hardt reiterated coverage of Amazon with a rating of Buy and set a new price target of $245.00 from $225.00 previously
Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and genetic testing, today reported its financial results for the third quarter ended September 30, 2024. Recent Strategic and Financial Highlights Generated total revenues of $439.8 million in the third quarter of 2024, compared to $268.3 million in the third quarter of 2023, a record increase of 63.9%. Product revenues grew 64.4% over the same period. Generated a gross margin of 61.8% in the third quarter of 2024, compared to a gross margin of 45.1% in the third quarter of 2023. Processed approximately 775,800 tests in the third quarter of 2024, compared to approximately 626,000 tests in the third quarter of 2023, an
FUJI SOFT's advisors, directors, and officers tendered ~90% of their share options Result means any plan to privatize FUJI SOFT will require KKR's support KKR, a leading global investment firm, today announced that in connection with its two-stage tender offer scheme (the "Tender Offer") for the common shares and share options of FUJI SOFT INCORPORATED (TSE stock code 9749; "FUJI SOFT") through FK Co., Ltd. (the "Offeror"), the Offeror, an entity owned by investment funds managed by KKR, completed the first of the two planned tender offers ("First Tender Offer") on November 5. With the completion of the First Tender Offer, the Offeror will become the largest shareholder of FUJI SOFT,
PHILADELPHIA and NEW YORK, Nov. 6, 2024 /PRNewswire/ -- FS KKR Capital Corp. (NYSE:FSK), or the Company, today announced its financial and operating results for the quarter ended September 30, 2024, and that its board of directors previously, on October 8, 2024, declared a fourth quarter 2024 distribution of $0.70 per share. Financial and Operating Highlights for the Quarter Ended September 30, 2024(1) Net investment income of $0.77 per share, compared to $0.77 per share for the quarter ended June 30, 2024Adjusted net investment income(2) of $0.74 per share, compared to $0.75
For Immediate Release: November 14, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Monday, the FDA updated the advisory for the Investigation of Elevated Lead Levels in Cinnamon Applesauce Pouches to include an expanded recall from WanaBana LLC to include Weis and Schnucks-brand cinnamon applesauce pouches. As of November 13, 2023, there
Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and genetic testing, today announced that its co-founder and executive chairman, Matthew Rabinowitz, PhD, has been named R&D Leader of the Year by R&D World. Established in 1963, the R&D 100 Awards program identifies and celebrates the top 100 revolutionary technologies of the past year. R&D World also has five professional awards given to individuals and/or teams, which in 2024, includes the award for Dr. Rabinowitz. In awarding this honor, R&D World referred to Dr. Rabinowitz as a "pioneering figure in genetic testing and precision medicine." The organization cited numerous achievements throughout his career at Natera, highl
Global Atlantic Financial Group ("Global Atlantic"), a leading insurance company meeting the retirement and life insurance needs of individuals and institutions – in partnership with the Bermuda Economic Development Corporation ("BEDC") – today announced the conclusion of the Second Annual Wave of Opportunity Pitch Competition. The co-sponsored event is designed to honor small business innovation and entrepreneurship in Bermuda. Hosted by Dr. Teneika Eve on November 21st at the Hamilton Princess Hotel & Beach Club, the competition had more than 100 people in attendance, demonstrating strong support for the eight finalists—five in the main category and three in the youth category—who showc
Underscores the Company's commitment to generating robust scientific evidence on its leading MRD technology Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and genetic testing, today announced that it has surpassed a key milestone with over 100 peer-reviewed publications on its personalized and tumor-informed molecular residual disease (MRD) test, Signatera. Multiple validation studies on Signatera have been published in top-tier journals like Nature, Nature Medicine, Nature Cancer, Journal of Clinical Oncology, Annals of Oncology, and JAMA Oncology. These include some of the largest and most comprehensive prospective studies of MRD testing to date. In clinical studies, S
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Reporting)
SC 13G/A - Natera, Inc. (0001604821) (Subject)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
SC 13G/A - AMAZON COM INC (0001018724) (Subject)
To gain an edge, this is what you need to know today. GDP Brings Buying Please click here for an enlarged chart of Invesco QQQ Trust Series 1 (NASDAQ:QQQ). Note the following: The chart shows a drop in QQQ. The drop in QQQ was triggered by speculative sentiment pulling back. As a reader of The Arora Report, you knew in advance that speculative sentiment could fall as a result of Tesla Inc (NASDAQ:TSLA) earnings. The chart shows that QQQ is approaching the support zone. RSI on the chart shows that QQQ is now oversold. Oversold markets tend to bounce. The chart shows that the volume was low on the selloff. This indicates a lack of conviction in selling. Especially hard hit in
Amazon.com Inc (NASDAQ:AMZN) shares are slightly lower Thursday. The company announced a strategic collaboration with GE HealthCare and was selected by the National Basketball Association (NBA) to telecast NBA games over the next decade. What Happened: GE HealthCare and Amazon Web Services (AWS) announced a strategic collaboration to develop foundation models and generative AI applications aimed at helping clinicians improve medical diagnostics and patient care. GE Healthcare said it will use AWS’s generative AI services to build and implement new foundation models. The models are expected to streamline healthcare operations, increase diagnostic and screening accuracy, enhance outcomes
"Hedging Is Gaining Traction" That's what Goldman Sachs's flow of funds guru Scott Rubner said in his note earlier today ("I Am Not Buying This Dip"). He also pointed out that four of the Magnificent Seven mega caps are reporting earnings next week: Microsoft Corporation (NASDAQ:MSFT), Meta Platforms, Inc. (NASDAQ:META), Apple, Inc. (NASDAQ:AAPL), and Amazon.com, Inc. (NASDAQ:AMZN), and that if their results and guidance are not "great", those stocks will likely get punished in this market environment. In the video below, I show inexpensive ways of hedging Microsoft and Meta ahead of their earnings next week. I mention a couple of times there that there's a link to download the newly
